Tocilizumab is a promising treatment option for therapy resistant juvenile localized scleroderma patients
Foeldvari, Ivan, Anton, Jordi, Friswell, Mark, Bica, Blanca, de Inocencio, Jaime, Aquilani, Angela, Helmus, NicolaVolume:
2
Language:
english
Journal:
Journal of Scleroderma and Related Disorders
DOI:
10.5301/jsrd.5000259
Date:
September, 2017
File:
PDF, 162 KB
english, 2017